BioLife Solutions Inc. (NASDAQ: BLFS) stock closed at 15.72 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 2.85M shares and market capitalization of 666.67M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 158 people. BioLife Solutions Inc. CEO is Michael Rice.

The one-year performance of BioLife Solutions Inc. stock is -64.59%, while year-to-date (YTD) performance is -57.82%. BLFS stock has a five-year performance of 557.74%. Its 52-week range is between 10.4 and 60.669, which gives BLFS stock a 52-week price range ratio of 10.58%

BioLife Solutions Inc. currently has a PE ratio of -39.60, a price-to-book (PB) ratio of 1.22, a price-to-sale (PS) ratio of 4.22, a price to cashflow ratio of 176.90, a PEG ratio of 2.32, a ROA of -3.46%, a ROC of -3.74% and a ROE of -3.95%. The company’s profit margin is -9.81%, its EBITDA margin is -17.50%, and its revenue ttm is $138.53 Million , which makes it $3.27 revenue per share.

Of the last four earnings reports from BioLife Solutions Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.09 for the next earnings report. BioLife Solutions Inc.’s next earnings report date is 11th Aug 2022.

The consensus rating of Wall Street analysts for BioLife Solutions Inc. is Strong Buy (1.25), with a target price of $32.71, which is +108.08% compared to the current price. The earnings rating for BioLife Solutions Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioLife Solutions Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioLife Solutions Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 12.67, ATR14 : 1.06, CCI20 : 252.64, Chaikin Money Flow : -0.11, MACD : 0.27, Money Flow Index : 77.67, ROC : 6.65, RSI : 60.66, STOCH (14,3) : 79.39, STOCH RSI : 1.00, UO : 53.44, Williams %R : -20.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioLife Solutions Inc. in the last 12-months were: Aby J. Mathew (Option Excercise at a value of $314 560), Aby J. Mathew (Sold 220 949 shares of value $9 284 693 ), Andrew G. Hinson (Sold 2 500 shares of value $111 275 ), Joseph Schick (Sold 3 250 shares of value $132 664 ), Karen Foster (Option Excercise at a value of $133 924), Karen Foster (Sold 102 931 shares of value $4 177 856 ), Marcus Schulz (Sold 16 317 shares of value $718 483 ), Michael Rice (Option Excercise at a value of $592 343), Michael Rice (Sold 382 515 shares of value $14 635 251 ), Roderick De Greef (Option Excercise at a value of $0), Roderick De Greef (Sold 259 400 shares of value $10 833 413 ), Sarah Aebersold (Sold 1 628 shares of value $64 081 ), Todd Berard (Option Excercise at a value of $107 027), Todd Berard (Sold 76 065 shares of value $2 921 098 ), Troy Wichterman (Sold 1 127 shares of value $21 496 )